Other
Oligometastatic
0
Pipeline Programs↗
5
Active Trials↗
0
Companies Involved↗
Oligometastatic is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
8
clinical trials
Recruiting4 · 50%
Unknown status2 · 25%
Not yet recruiting1 · 13%
Completed1 · 13%
Clinical Trials
Trial Activity
8 trials
PFLL Combined With PD-1 Antibody With or Without FMT for Oligometastatic NPC,a Phase III ,Open, Randomized Clinical Trial.
Not yet recruiting·—·Phase 3·NCT06486220·96 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)